InnoCare Pharma Limited 諾誠健華醫藥有限公司
Climate Impact & Sustainability Data (2019, 2020, 2022, 2023)
Reporting Period: 2019
Environmental Metrics
ESG Focus Areas
- Corporate governance
- Anti-corruption
- Talent attraction and retention
- R&D and innovation
- Product quality and safety
- Waste management
- Chemical management
- Animal welfare
- Career development
- Occupational health and safety (OHS)
- Supply chain management
- Intellectual property protection
- Data and privacy protection
- Energy consumption
- Emissions management
- Legal employment
- Community contribution
- Climate change
Environmental Achievements
- Invested RMB727,700 in environmental protection and encountered no environmental accidents such as chemical leakage.
- Saved about 61,000 kWh of electricity through energy-saving measures.
- Consumed 13,200 tons of water during the reporting period with no issues in sourcing fit-for-purpose water.
- Registered no soil erosion incidents in the project construction area and no adverse impact on the environment during the reporting period.
Social Achievements
- No work-related accidents; zero hours lost due to work-related injuries.
- 100% safety training coverage with 30 hours of per-capita training.
- Total person times of staff training reached 4,676.
- Donated RMB one million to the Chinese Red Cross Foundation to help control the COVID-19 pandemic.
- Donated surgical masks to Shanghai Oriental Hospital and an American organization.
Governance Achievements
- Established a Safety Committee to implement a safety responsibility system and regulate EHS management.
- Established rigorous Quality Risk Management Procedures.
- Developed a series of 168 clinical standard operating procedures (SOPs).
- No cases of corruption during the reporting period.
Climate Goals & Targets
Environmental Challenges
- Supply chain risks in areas including compliance of suppliers, intellectual property infringement, raw material and component quality, severe weather and natural or man-made disaster.
Mitigation Strategies
- Clear systems and specifications, management measures, and supplier training to reduce supply chain risks.
- On-site supplier audits for raw and auxiliary materials and internal packaging materials.
- EHS audit and supervision requirements for contractor selection on projects under construction.
Supply Chain Management
Supplier Audits: Annual audits conducted on suppliers of raw and auxiliary materials and internal packaging materials.
Responsible Procurement
- Purchase Management System
- Warehouse Management System
- Plan Management System
- Supplier Management
- Material Supplier Management
- Consumables Supplier Management
- Supplier Monitoring and Maintenance
- Supplier Complaint Management
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: GRI Standards for Sustainability Reporting, ESG Reporting Guide
Reporting Period: 2020
Environmental Metrics
ESG Focus Areas
- Environmental Protection
- People-oriented
- Responsible Operation
- Product Liability
- Community Engagement
Environmental Achievements
- Reduced experimental wastewater discharge by 49% compared to 2019 (1,208 tonnes vs 2,370 tonnes)
- Implemented energy-saving measures such as LED lighting and temperature controls in offices and laboratories.
- Implemented waste reduction initiatives, including paperless office initiatives and waste recycling programs.
Social Achievements
- No labor disputes or child labor incidents.
- No work-related deaths or lost workdays due to injuries.
- Provided various employee benefits, including social insurance, housing provident fund, and other welfare payments.
- Conducted extensive employee training programs (2,081 female and 2,535 male employee training hours).
Governance Achievements
- Established an ESG working group to oversee ESG policies and strategies.
- Implemented an internal audit management system to strengthen internal controls and prevent illegal activities.
- Formulated anti-commercial bribery and conflict of interest management agreements.
- Established whistleblowing procedures for reporting unethical behavior.
Climate Goals & Targets
Environmental Challenges
- Large-scale construction of Guangzhou manufacturing facility impacting energy and water consumption.
- Managing environmental risks during the construction phase of the Guangzhou facility.
Mitigation Strategies
- Regular monitoring and evaluation of environmental risks during construction.
- Implementation of drainage ditches, sediment deposit ponds, and other greening measures to mitigate environmental impact.
Supply Chain Management
Supplier Audits: 844 suppliers (783 in Mainland China, 61 overseas)
Responsible Procurement
- Purchasing Management System
- Supplier Management
- Material Supplier Management
- Consumables Supplier Management
- Contractor Management
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: Hong Kong Stock Exchange ESG Reporting Guide
Awards & Recognition
- 2020 Humanitarian Dedication Angel
Reporting Period: 2022
Environmental Metrics
ESG Focus Areas
- Corporate Governance
- Product and Service Responsibility
- Talent Development
- Environmental Protection
- Responsible Operation
- Social Welfare
Environmental Achievements
- Obtained ISO 14001 Environmental Management System Certification at Guangzhou production base.
- Completed construction of biologics R&D platform project with environmental impact assessments and mitigation measures.
Social Achievements
- Upgraded supplementary commercial insurance for employees, including coverage for two children and critical illness insurance.
- Provided various employee care initiatives, including assistance for employees in economic difficulty, health supplies distribution, and psychological counseling.
- Achieved 100% employee training coverage.
Governance Achievements
- Issued anti-corruption and anti-bribery policies.
- Formulated the Reporting Policy for managing reporting incidents and protecting reporters.
- No major or significant deficiencies identified in internal control.
Climate Goals & Targets
Environmental Challenges
- Meeting more stringent domestic and international climate policies, laws, and regulations.
- Potential damage to reputation due to insufficient climate response actions.
- Potential impact of acute and chronic physical climate risks on operations and finances.
Mitigation Strategies
- Analyzing potential financial impact of climate risks and opportunities.
- Developing future plans integrating climate change risk management into overall operational risk management.
- Implementing measures to improve resource efficiency and develop resilience to climate change.
Supply Chain Management
Supplier Audits: 0 suppliers evaluated for environmental and social impacts
Responsible Procurement
- Multi-dimensional background investigation on suppliers.
- Regular meetings and communication with key suppliers.
- Periodic quality history evaluations.
Climate-Related Risks & Opportunities
Physical Risks
- Acute physical risks (extreme weather events)
- Chronic physical risks (long-term weather pattern changes)
Transition Risks
- Policies, laws, and regulations
- Reputation
Opportunities
- Resource efficiency
- Resilience
Reporting Standards
Frameworks Used: HKEX ESG Reporting Guide, Shanghai Stock Exchange Guidelines No. 1 and No. 2
Certifications: ISO 14001, ISO 45001
Awards & Recognition
- Golden Yue Award - 2022 Company of the Year Public Responsibility
- Most Valuable Pharmaceutical and Medical Company
- Most Valuable IPO of the Year
- Best IR Award
Reporting Period: 2023
Environmental Metrics
ESG Focus Areas
- Corporate Governance
- Product and Service Responsibility
- Talent Development
- Environmental Protection
- Social Welfare
Environmental Achievements
- Reduced carbon emissions by 144.9 tons through recycling 96.6 tons of waste methanol at the Guangzhou base.
Social Achievements
- Enhanced employee engagement and happiness through diversification initiatives, including lectures, online courses, and management training.
- Achieved zero reports of adverse reactions stemming from medication defects.
- Reduced employee turnover by 1.95% compared to the previous year (from 15.26% to 13.31%).
Governance Achievements
- Established a top-down ESG governance structure with a Board of Directors and an ESG Working Group.
- Implemented the Quality Risk Management Procedures and established a comprehensive quality management system.
- Formulated a comprehensive compliance management system incorporating international and domestic standards (ISO 37301).
Climate Goals & Targets
- Reduce energy use intensity by 10% by 2028 (from 2023 baseline).
- Reduce industrial wastewater discharge intensity by 10% by 2028 (from 2023 baseline).
- Reduce greenhouse gas emission intensity by 10% by 2028 (from 2023 baseline).
Environmental Challenges
- Operational risks
- Adverse drug reaction risk
- Financial risk
- Credit risk
- EHS risk
- Compliance risk
- Information security risk
- Climate-related risks (acute physical, chronic physical, policy and regulations, reputational)
- Non-climate related risks (not explicitly stated, but implied through general risk management discussion)
Mitigation Strategies
- Systematic operational analysis and monthly risk assessments.
- Effective adverse drug reaction event reporting mechanism.
- Annual budget management, digital tools for efficiency, and capital reserves.
- Strict distributor access system and accounts receivable management.
- Comprehensive EHS training system and regular safety inspections.
- Comprehensive compliance management system with internal audits and risk assessments.
- Comprehensive information security management system with regular updates and employee training.
- Integration of climate change risk management into daily work processes (ongoing).
- Various risk management systems and procedures (detailed in the report).
Supply Chain Management
Supplier Audits: 0 in 2023 for environmental and social impacts; 2 on-site audits of entrusted manufacturers for quality management.
Responsible Procurement
- Multi-dimensional background checks on suppliers.
- Quality assessment questionnaires and on-site audits.
- Regular quality re-audits.
- Bi-weekly online meetings and annual on-site communication with key suppliers.
- Periodic quality history evaluations.
Climate-Related Risks & Opportunities
Physical Risks
- Acute physical risks (extreme weather events)
- Chronic physical risks (long-term weather pattern changes)
Transition Risks
- Policy and regulatory risks (changes in climate policies and regulations)
- Reputational risks (failure to take proactive climate action)
Opportunities
- Resource efficiency (improving resource use efficiency)
- Adaptability (developing adaptability to climate change)
Reporting Standards
Frameworks Used: HKEX Environmental, Social and Governance Reporting Guide, Guidelines No. 2 for Application of Self-Regulation Rules for Companies Listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange
Certifications: ISO 14001 (Guangzhou InnoCare), ISO 45001 (Guangzhou InnoCare)
Awards & Recognition
- China’s Top 20 Listed Pharmaceuticals in ESG Competitiveness 2023
- Most Socially Responsible Pharmaceuticals of the 2023 Sina Finance “Golden Kirin”
- List of Innovative Listed Pharmaceuticals of the 2023 Future Healthcare VB100 Awards
- Top 10 Influential New Technologies and Products (ICP-332)
- 3rd Excellent Healthcare Employer of the Year (2023)
- Investor Relations Pioneer Award of iFinD Enterprise Account in 2022
- China’s New Economy Enterprise Top 500 for 2022
- Top 10 Innovative Pharmaceutical Enterprises of the Golden Walking Stick 2023